Video

New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients

While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.

News

Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials

Using bone marrow and blood to identify specific biomarkers, a new “umbrella” screening study matches patients diagnosed with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) to one of five clinical trials evaluating precision-medicine ...

News

Roswell Park Experts Share Latest Hematology Research at 67th ASH Annual Meeting

Experts from Roswell Park Comprehensive Cancer Center will discuss their latest discoveries at the 67th annual meeting of the American Society of Hematology (ASH) December 6-9 in Orlando, Florida.

News

Roswell Park Experts Host Symposium to Reconnect the “Meaning in Medicine”

Join leaders from Roswell Park Comprehensive Cancer Center, along with speakers from Levine Cancer Institute and the Jacobs School of Medicine at the State University of New York at Buffalo for a special day-long symposium, “Finding the ...

News

Could Psychedelic Drugs Relieve Cancer Pain?

Roswell Park’s Palliative Care team explores surprising new ways to tackle both the physical and psychological sources of cancer pain.

Video

Roswell Park Offers Exclusive CAR T-Cell Clinical Trial for Patients with Advanced or Metastatic Hepatoma

 A new, first-in-humans clinical trial for hepatocellular carcinoma uses an “armored” CAR T-cell therapy designed to resist the hostile tumor microenvironment found in 77% of patients with this disease.